All In Biotech

NDA 205434 · Haleon US Holdings

Flonase Allergy Relief

Fluticasone Propionate · Nasal

Last checked: Nov 20, 2026Latest source record: Dec 19, 2025 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

2014

Jul 23, 2014

Approved uses

1

Original approval plus efficacy supplements

Registered trials

738

240 Phase 3, 19 recruiting

FAERS reports

93,660

45,178 serious, 4,248 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Dec 19, 2024.

Uses Temporarily relieves these symptoms of hay fever or other upper respiratory allergies: • nasal congestion • itchy nose • runny nose • itchy, watery eyes • sneezing

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Jul 23, 2014 Original approval · Type 8 - Partial Rx to OTC Switch LabelLetterReview
1 products under this application
  • FLONASE ALLERGY RELIEF · FLUTICASONE PROPIONATE 0.05MG/SPRAY · SPRAY, METERED, NASAL · Over-the-counter

Clinical trials

Interventional ClinicalTrials.gov studies with "Fluticasone Propionate" as an intervention, any sponsor and status, largest first.

All 738 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • drug ineffective7,936
  • headache6,387
  • fatigue6,263
  • dyspnoea6,232
  • nausea5,479
  • pain4,829
  • diarrhoea4,712
  • cough4,434
  • off label use4,337
  • dizziness4,161
  • pneumonia3,468
  • asthma3,231

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
20041,454
20051,543
20061,479
20071,222
20081,131
20091,191
20101,658
20112,027
20122,500
20131,854
20142,311
20155,773
20167,773
20175,677
20185,868
20195,960
20206,402
20215,514
20225,753
20236,080
20247,320
20257,393
20265,773

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 1,187 on PubMed

Sponsor: Haleon US Holdings

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.